Amplifier Therapeutics
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- Undisclosed
Investors
- 3
About Amplifier Therapeutics
a Amplifier Therapeutics is a biopharmaceutical company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging, including metabolic conditions, cardiovascular diseases, kidney diseases, and cancer. The company engages in the development of a compound called ATX-304, which activates AMPK. ATX-304 has the potential to treat various conditions, particularly those related to aging, such as heart and kidney diseases, diabetes, and cancer. It may also be a potential treatment for obesity.
Who invested in Amplifier Therapeutics
3 investors across 1 round
See all investors in Amplifier Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 17, 2023
Amount
Undisclosed
Investors
Questions about Amplifier Therapeutics
Who invested in Amplifier Therapeutics?
Amplifier Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amplifier Therapeutics raised?
Amplifier Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amplifier Therapeutics last raise money?
Amplifier Therapeutics's most recent round on record is a Series A, in Oct 2023.
What does Amplifier Therapeutics do?
a Amplifier Therapeutics is a biopharmaceutical company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging, including metabolic conditions, cardiovascular diseases, kidney diseases, and cancer.
Where is Amplifier Therapeutics headquartered?
Amplifier Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Amplifier Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amplifier Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Amplifier Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.